Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
JBRA Assist Reprod ; 2024 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-38848251

RESUMO

OBJECTIVE: This study examined whether blastocysts transferred on day 5 or day 6 of embryo development, as well as positivity for anti-thyroid peroxidase antibodies, affect gestational outcomes in euthyroid women undergoing in vitro fertilisation. METHODS: Of 428 women who underwent in vitro fertilisation assessed in this retrospective cohort study, 212 (49.5%) underwent embryo transfer on day 5 of blastulation and 216 (50.5%) on day 6. Dichotomization based on anti-thyroid peroxidase antibodies status was also performed, with 370 (86.4%) women testing negative and 58 (13.6%) testing positive. Clinical and hormonal data and rates of clinical pregnancy, miscarriage, and live births were compared between the groups. RESULTS: When evaluating gestational outcomes based on the day of blastulation, a statistically significant difference was observed in clinical pregnancy rates [51.4% (day 5) vs. 40.7% (day 6); p=0.033]. However, there was no significant difference in the relative frequencies of miscarriages (p=1.000), live births (p=1.000), or preterm births (p=1.000). Using Cramer's V test, a weak association was found between the day of blastulation and clinical pregnancy outcomes (V2=10.7%; p=0.027). There were no statistically significant differences between the anti-thyroid peroxidase antibodies-negative and -positive groups in terms of clinical pregnancy rates (p=0.396), miscarriages (p=0.129), and live births (p=0.129). CONCLUSIONS: Higher rates of clinical pregnancy were observed in women who underwent embryo transfers performed on day 5 compared to those on day 6. However, no effect was observed with gestational outcomes. Further, anti-thyroid peroxidase antibody positivity did not have a statistically significant impact on gestational outcomes.

2.
Front Endocrinol (Lausanne) ; 13: 1023635, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36299456

RESUMO

Background: The influence of thyroid-stimulating hormone (TSH) on gestational outcomes have been studied and checked whether differing TSH levels are relevant on human reproduction outcomes. International guidelines recommend TSH values <2.5 mIU/L in women trying to conceive, since values above this level are related to a higher frequency of adverse reproductive outcomes. This study aimed to evaluate whether TSH values correlate with different gestational outcomes in euthyroid infertile women without autoimmune thyroid disease. Methods: A retrospective cohort study was conducted involving 256 women who underwent in vitro fertilization (IVF) treatment. The participants were divided into two groups: TSH 0.5-2.49 mIU/L (n=211) and TSH 2.5-4.5 mIU/L (n=45). The clinical data, hormonal profiles and reproductive outcomes were compared between groups. Additionally, a systematic review with meta-analysis following the PRISMA protocol was carried out in PubMed/MEDLINE, EMBASE, and SciELO, with no time or language restrictions, for articles comparing TSH groups named "low TSH" (<2,5 mIU/L) and "high TSH" (≥2.5 mIU/L). A meta-analysis of proportions was performed with pooled estimates expressed as relative risk (RR) of events and a random effects model. Results: Age, BMI, free thyroxine levels (FT4) hormonal profile and IVF outcomes were not different between groups, neither gestational outcomes (p=0.982). Also, no difference was observed when the TSH and FT4 levels were compared between patients with positive or negative gestational outcomes (p=0.27 and p=0.376). Regarding the systematic review with meta-analysis, 17 studies from 2006 to 2022 were included, and added by this original retrospective research comprising 13.247 women undergoing IVF. When comparing the proportions of clinical pregnancy between the TSH groups, no significant difference was found (RR 0.93, 95% CI 0.80-1.08), with high between studies heterogeneity (I²: 87%; τ2: 0.0544; p<0.01). The number of deliveries was not significantly different between groups, despite a trend towards higher frequency in the high-TSH group (RR 0.96, 95% CI 0.90-1.02). Conclusion: Variation in TSH levels within the normal range was not associated with pregnancy and delivery rates in women, without autoimmune thyroid disease, who underwent IVF treatment. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD 42022306967.


Assuntos
Infertilidade Feminina , Doenças da Glândula Tireoide , Gravidez , Humanos , Feminino , Infertilidade Feminina/complicações , Tiroxina/uso terapêutico , Estudos Retrospectivos , Análise de Dados , Tireotropina , Resultado da Gravidez , Doenças da Glândula Tireoide/complicações
3.
Rev. bras. saúde mater. infant ; 10(1): 69-74, Jan.-Mar. 2010. tab, ilus
Artigo em Inglês | LILACS | ID: lil-550752

RESUMO

OBJECTIVES: to compare the levels of cortisol (cortisolemia refers to the level of cortisol in blood) in women with a high-risk pregnancy compared with those with a low-risk pregnancy, by way of evaluation of levels of cortisol in saliva, using the electrochemical luminescence technique (ECL). METHODS: 38 women aged between 17 and 40 years in the third trimester of pregnancy were divided in two groups: 20 low-risk pregnancies and 18 high-risk ones. Cortisol in saliva was collected at midnight and measured using ECL. The mean levels of cortisol in saliva in the two groups were compared using the Kruskal-Wallis test. RESULTS: the mean systolic and diastolic pressure was normal in both groups. The levels of cortisol in the saliva of women with high-risk pregnancies was significantly higher than those for the low-risk pregnancy group (20.2 (±21,1) nmol/L vs 11.4(±16.2) nmol/L; p=0.007). CONCLUSIONS: a high risk pregnancy involves higher levels of cortisol than a low-risk one. The levels of cortisol in saliva, as measured using ECL, can be used to identify hypercortisolism in pregnancy.


OBJETIVOS: comparar os níveis de cortisol em mulheres com gravidez de alto risco em relação às gestantes de baixo risco, por meio da avaliação do cortisol salivar utilizando a técnica da electroquimioluminescência (EQL). MÉTODOS: foram estudadas 38 mulheres de 17a 40 anos de idade, no terceiro trimestre de gestação, divididas em dois grupos: 20 gestantes de baixo risco e 18 gestantes de alto risco. O cortisol salivar foi coletado à meia-noite e medido através da EQL. As médias do cortisol salivar foram comparadas entre os dois grupos de gestantes através do teste de Kruskal-Wallis. RESULTADOS: a média das pressões sistólica e diastólica foi normal nos dois grupos. O cortisol salivar das gestantes de alto risco foi significativamente mais elevado do que das gestantes baixo risco: (20,2 (±21,1) nmol/L vs 11,4(±16,2) nmol/L; p=0,007). CONCLUSÕES: a gestação de alto risco cursa com níveis mais elevados de cortisol quando comparada à gestação de baixo risco. O cortisol salivar, medido pelo EQL mostrou-se promissor para identificar o hipercortisolismo na gestação.


Assuntos
Humanos , Gravidez , Hidrocortisona , Gravidez de Alto Risco
4.
Rheumatol Int ; 30(8): 1055-61, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19714333

RESUMO

In South America the incidence of Paget's disease of bone (PDB) is low and more than half of the cases published in the last 30 years come from Brazil and Argentina. The aim of this study was to describe the clinical and epidemiological characteristics of PDB in two institutions in Pernambuco. PDB patients in Recife, Brazil were studied retrospectively. A total of 108 cases were diagnosed from 1984 to 2005. Over 90% of the patients were of European descent. The average age was 66.2 years and 49.1% were male. The polyostotic form was the more common. Pain and bone deformity were significantly more frequent in this group and in the total group. Clear eyes were observed in 22.2% of the patients and 23.1% had a family history record of PDB. The most frequently affected bones were the pelvis, lumbar vertebrae, femurs, and skull. Zoledronate was the most effective drug in reducing the alkaline phosphatase. Our data show that PDB in Recife occurs predominantly among those of European descents, usually in the polyostotic presentation, thus providing evidence of genetic and historical factors in the prevalence of PDB in that region.


Assuntos
Osteíte Deformante/diagnóstico , Osteíte Deformante/epidemiologia , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Brasil/epidemiologia , Europa (Continente)/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Osteíte Deformante/etnologia , Estudos Retrospectivos , Distribuição por Sexo , População Branca
5.
Arq Bras Endocrinol Metabol ; 50(4): 814-22, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17117306

RESUMO

Paget's disease of bone is a focal disorder of bone remodeling accompanied initially by an increase in bone resorption, followed by a disorganized and excessive formation of bone, leading to pain, fractures and deformities. It exhibits a marked geographical variation in its prevalence. In Brazil it predominantly affects persons of European descent. The majority of the reported cases of the disease in Brazil are from Recife, owing to its peculiar mixed European colonization over approximately four centuries. The etiology is complex and involves both genetic and environmental factors. The disease is often asymptomatic and diagnosis is usually based on biochemical markers of bone turnover, radionuclide bone scan and radiological examination. Bisphosphonates, in particular zoledronic acid, are regarded as the treatment of choice for Paget's disease of bone.


Assuntos
Osteíte Deformante , Brasil/epidemiologia , Seguimentos , Humanos , Osteíte Deformante/diagnóstico , Osteíte Deformante/epidemiologia , Osteíte Deformante/terapia
6.
Arq. bras. endocrinol. metab ; Arq. bras. endocrinol. metab;50(4): 814-822, ago. 2006. graf, tab
Artigo em Inglês, Português | LILACS | ID: lil-437631

RESUMO

Paget's disease of bone is a focal disorder of bone remodeling accompanied initially by an increase in bone resorption, followed by a disorganized and excessive formation of bone, leading to pain, fractures and deformities. It exhibits a marked geographical variation in its prevalence. In Brazil it predominantly affects persons of European descent. The majority of the reported cases of the disease in Brazil are from Recife, owing to its peculiar mixed European colonization over approximately four centuries. The etiology is complex and involves both genetic and environmental factors. The disease is often asymptomatic and diagnosis is usually based on biochemical markers of bone turnover, radionuclide bone scan and radiological examination. Bisphosphonates, in particular zoledronic acid, are regarded as the treatment of choice for Paget's disease of bone.


Doença de Paget óssea é uma desordem focal da remodelação óssea, inicialmente acompanhada de um aumento da reabsorção óssea, seguida de desorganizada e excessiva formação óssea, levando a dor, deformidades e fraturas. Exibe uma variável distribuição geográfica em sua prevalência. No Brasil acomete predominantemente pacientes de descendência européia. Recife, devido à sua peculiar colonização mista européia por cerca de 4 séculos, tem a maioria dos casos relatados no Brasil. A etiologia é complexa e envolve fatores ambientais e genéticos. A doença é freqüentemente assintomática e o diagnóstico é feito usualmente através dos marcadores bioquímicos do turnover ósseo associado a cintilografia óssea e dos sinais típicos do exame radiológico. Os bisfosfonatos representam o tratamento de escolha na doença de Paget óssea, particularmente o ácido zolidrônico.


Assuntos
Humanos , Osteíte Deformante , Brasil/epidemiologia , Seguimentos , Osteíte Deformante/diagnóstico , Osteíte Deformante/epidemiologia , Osteíte Deformante/terapia
7.
Rev. bras. ciênc. saúde ; 5(1): 75-80, jan. 2001. ilus
Artigo em Português | LILACS | ID: lil-286685

RESUMO

A autora relata um caso de seqüestração pulmonar, cujo diagnóstico foi estabelecido após suspeita radiográfica; enfatiza a importância desta anomalia congênita pelas dificuldades do seu diagnóstico, que só é realizado quando já se conhece e se pensa nela; revisa a literatura acerca do tema em foco, abordando todos os aspectos diagnósticos, momento em que tangenciam a imagenologia e, por fim, tece considerações sobre a abordagem terapêutica da mesma


Assuntos
Humanos , Feminino , Adulto , Cisto Broncogênico , Sequestro Broncopulmonar/diagnóstico , Pneumologia
8.
Odontol. mod ; 20(3): 28-33, maio-jun. 1993. tab
Artigo em Português | BBO - Odontologia | ID: biblio-852640

RESUMO

Os autores apresentam o tema erupção dentária, com a finalidade de observar e analisar o conceito discriminativo deste assunto (fisiológico ou patológico) que é transmitido à comunidade (pais e responsáveis), bem como analisar a clientela estudada e se o tempo de profissão interfere nesta concepção conceitual. A literatura é vasta. Enfocam-se a sequência de erupções, cronologia da erupção, patologias, assim como as manifestações somáticas gerais e (ou) locais. Catalogam-se as observações mais frequentes


Assuntos
Dente Decíduo/crescimento & desenvolvimento , Odontopediatria , Erupção Dentária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA